Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brodfuehrer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1990
Flavone acetic acid and plasma protein bindingJ Brodfuehrer, F Valeriote, K Chan, et al.
Cancer|January 15, 1991
A dose-intensive regimen of 5-fluorouracil for the treatment of metastatic colorectal carcinomaE A Poplin, M Kraut, L Baker, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 2010
Understanding the clinical pharmacokinetics of a GABAA partial agonist by application of in vitro toolsAarti D Sawant, E L Miller, D B Duignan, et al.
Journal of Medicinal Chemistry|June 29, 2001
4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parametersS E Hagen, J Domagala, C Gajda, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic propertiesJ V Vara Prasad, F E Boyer, J M Domagala, et al.
Journal of Medicinal Chemistry|March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV proteaseF E Boyer, J V Vara Prasad, J M Domagala, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|January 1, 1990
Flavone acetic acid and plasma protein bindingJ Brodfuehrer, F Valeriote, K Chan, et al.
Cancer|January 15, 1991
A dose-intensive regimen of 5-fluorouracil for the treatment of metastatic colorectal carcinomaE A Poplin, M Kraut, L Baker, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 2010
Understanding the clinical pharmacokinetics of a GABAA partial agonist by application of in vitro toolsAarti D Sawant, E L Miller, D B Duignan, et al.
Journal of Medicinal Chemistry|June 29, 2001
4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parametersS E Hagen, J Domagala, C Gajda, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic propertiesJ V Vara Prasad, F E Boyer, J M Domagala, et al.
Journal of Medicinal Chemistry|March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV proteaseF E Boyer, J V Vara Prasad, J M Domagala, et al.
Pageof 1